Srikripa Devarakonda
Stock Analyst at Truist Securities
(3.7)
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
REGN Regeneron Pharmaceut... | Maintains: Buy | 940 812 | 590.65 | 37.48% | 8 | Aug 11, 2025 | |
INCY Incyte | Maintains: Hold | 73 79 | 85.49 | -7.59% | 11 | Jul 30, 2025 | |
ARVN Arvinas | Downgrades: Hold | 21 11 | 7.33 | 50.07% | 1 | May 5, 2025 | |
BIIB Biogen | Maintains: Buy | 210 199 | 138.95 | 43.22% | 4 | Apr 29, 2025 | |
KROS Keros Therapeutics | Maintains: Buy | 43 25 | 15.67 | 59.54% | 5 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 60 76 | 57.69 | 31.74% | 2 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 1029 1038 | 710.6 | 46.07% | 4 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 211 217 | 209.56 | 3.55% | 3 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 36 32 | 25.78 | 24.13% | 1 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 33 50 | 14.84 | 236.93% | 6 | Nov 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 36 45 | 35.65 | 26.23% | 4 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 54 53 | 44.01 | 20.43% | 3 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 54 54 | 1.81 | 2883.43% | 1 | Sep 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 18 15 | 9.25 | 62.16% | 7 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 36 | 10.07 | 257.5% | 1 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 86 70 | 38.49 | 81.87% | 4 | May 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 80 60 | n/a | n/a | 2 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 38 | n/a | n/a | 3 | Mar 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 50 34 | n/a | n/a | 2 | Jun 3, 2021 |